INDIRECT TREATMENT COMPARISON OF NIVOLUMAB VERSUS PLACEBO AS ADJUVANT TREATMENT FOR MELANOMA

Category Primary study
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Year 2020
This article has no abstract
Epistemonikos ID: 23bae80daa8c26293db5831655df9a9e4c86e0d8
First added on: Feb 12, 2025